InvestorsHub Logo
Followers 79
Posts 1668
Boards Moderated 0
Alias Born 08/26/2008

Re: None

Friday, 12/12/2014 5:09:03 PM

Friday, December 12, 2014 5:09:03 PM

Post# of 6805
Daniel Ward re: DARA



"The company has been able to increase revenues in the past two quarters all while reducing expenses each time. Expenses have recently trended slightly to the downside due to small reductions in marketing expenses."



http://seekingalpha.com/article/2749955-dara-biosciences-an-attractive-small-cap-breast-cancer-stock-with-potential-catalysts?uide=1872771&uprof=51

HALF and HALF
Bavituximab and (?) So the music plays on!